Asia Pacific Polio Vaccine Market Size By Type (Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV)), By Application (Public, Private), By Geographic Scope And Forecast

Asia Pacific Polio Vaccine Market Size And Forecast

Asia Pacific Polio Vaccine Market size was valued at USD 368.8 million in 2022 and is projected to reach USD 507.3 million by 2030, growing at a CAGR of 4.17% from 2024 to 2030.

The Asia-Pacific region has been actively engaged in efforts to combat polio through vaccination campaigns and initiatives. These efforts are part of the broader global goal to eradicate polio and prevent its resurgence. These factors will propel the demand for polio vaccine in the regional market. The Asia Pacific report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Asia Pacific Polio Vaccine Market Definition

The polio vaccine is a critical medical innovation developed to combat poliomyelitis, commonly referred to as polio. Polio is a highly contagious viral disease caused by the poliovirus, which primarily targets the nervous system, potentially resulting in paralysis, muscle weakness, and even death. The consequences of polio can be devastating, particularly for young children, making the development and distribution of vaccines a crucial public health initiative.

Asia Pacific Polio Vaccine Market Overview

The rising awareness of preventive medicine, coupled with efforts by government and non-government organizations to promote vaccination and disease eradication, has a significant impact on the Polio vaccine market in Asia Pacific countries. Government-driven initiatives, such as the Polio eradication strategy 2022-2026 by the Global Polio Eradication Initiative (GPEI), demonstrate a commitment to public health and disease eradication. These strategies set specific goals and timelines for vaccine-preventable disease elimination, which includes polio. Such clear objectives and action plans enhance the credibility of vaccination campaigns and inspire public confidence in bacterial vaccines. Many developing countries in the Asia Pacific region have vast rural populations with limited access to healthcare facilities. The focus on reaching out to uneducated people, especially in rural areas, ensures that preventive medicine messages and vaccination campaigns are inclusive and reach all segments of the population. This comprehensive approach helps create widespread awareness about the importance of vaccination in disease prevention, thus increasing the demand of polio vaccines.

The escalating demand for polio vaccine is closely intertwined with several factors, including the burgeoning global population and the consistent rate of childbirths. In some regions, particularly conflict zones or remote areas, healthcare workers face challenges in accessing communities to administer vaccines. Limited infrastructure and difficult terrain can hinder vaccination campaigns. Misinformation, lack of awareness, and vaccine hesitancy contribute to low vaccine acceptance rates in certain communities. Rumors and misconceptions about vaccines can deter parents from getting their children immunized. These are some of the factors that are hindering the growth of the polio vaccine market in the region.

Asia Pacific Polio Vaccine MarketSegmentation Analysis

Asia Pacific Polio Vaccine Market is segmented based on Type, Application, And Geography.

Asia Pacific Polio Vaccine Market, By Type

• Inactivated polio vaccine (IPV)• Oral Polio Vaccines

Based on Type, the market is segmented into Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). The oral polio vaccine segment will have highest market share in segment held the highest market share in the Asia Pacific polio vaccine market in the year 2022. The oral polio vaccine uses strains that are help to produce antibodies to counter wild or naturally occurring polio virus among children. Also, the easy availability and ease in consumption is a positive factor. This is augmenting the growth of the Oral Polio Vaccine segment.

Asia Pacific Polio Vaccine Market, By Application

• Public• Private

Based on Application, the market is segmented into public & private. The public segment will have the highest market share in the assessment timeline. Public agencies and governments in the Asia-Pacific region have been actively involved in polio vaccination campaigns to eradicate the disease. Many countries in the region have integrated polio vaccines into their routine immunization schedules. Governments and health agencies also focus on monitoring for potential polio cases and conducting surveillance to quickly detect and respond to any outbreaks. These factors will propel the market share for the public segment in the assessment timeline.

Asia Pacific Polio Vaccine Market, By Geography

• China• India• Japan• Rest of Asia Pacific

On the basis of Geography, the Asia Pacific Polio Vaccine market is classified into China, India, Japan, and the Rest of Asia Pacific. China will hold the highest market share in the Asia Pacific Polio Vaccine market in the year 2022. China has a history of successful vaccination campaigns, driven by strong government commitment, partnerships with international organizations, and community health worker programs. The countries expanding healthcare infrastructure, government initiatives, and collaborations with international organizations have contributed to successful polio eradication efforts. This will lead to a growing share of the country in the assessment timeline.

Key Players

The “Asia Pacific Polio Vaccine Market” study report will provide valuable insight with an emphasis on the Asia Pacific market including some of the major players of the industry are Sanofi S.A., GSK, Serum Institute, Bharat Biotech, Novartis International AG, Sinovac Biotech, Panacea Biotec Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd., Merck & Co., Inc., Bio-Med (P) Limited, among other. Our market analysis offers detailed information on major players wherein our analysts provide insight into the financial statements of all the major players, product portfolio, product benchmarking, and SWOT analysis. The competitive landscape section also includes market share analysis, key development strategies, recent developments, and market ranking analysis of the above-mentioned players in Asia Pacific.

Key Developments

• In August 2023, Novartis International AG announced that the company had acquired Chinook Therapeutics, Inc., a biopharmaceutical company. This will help the company to increase its market presence globally.
• In June 2022, GSK announced that it will accelerate its Research & and development activities, and invest around 1 billion euros in the development of vaccines and medicines for various infectious diseases.
• In March 2021, Sanofi S.A. announced that it will invest more than 600 million euros to develop new vaccines at its manufacturing facility in Canada. This will help the company to broaden its product offering and product portfolio.

Report Scope

To Get Customized Report Scope- 

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.